论文信息 - The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration. - 字舞流文

The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration.

F. Ralley | Fiona E. Ralley

[1] R. Kacmarek. Update on the Use of Inhaled Nitric Oxide , 1996 .

[2] J. Wain,et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. , 1991, Anesthesiology.

[3] J. Weiler,et al. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardiopulmonary bypass surgery. , 1990, The Journal of allergy and clinical immunology.

[4] D. Benhamou,et al. Effects of age on plasma protein binding of sufentanil. , 1987, Anesthesiology.

[5] E. Lowenstein. Lessons from studying an infrequent event: adverse hemodynamic response associated with protamine reversal of heparin anticoagulation. , 1989, Journal of cardiothoracic anesthesia.

[6] J. Repine,et al. Acute Pulmonary Vasoconstriction and Thromboxane Release During Protamine Reversal of Heparin Anticoagulation in Awake Sheep: Evidence for the Role of Reactive Oxygen Metabolites Following Nonimmunological Complement Activation , 1988, Circulation research.